Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry
Gibson, Peter G, Reddel, Helen, McDonald, Vanessa M, Marks, Guy, Jenkins, Christine, Gillman, Andrew, Upham, John, Sutherland, Michael, Rimmer, Janet, Thien, Frank, Katsoulotos, Greg P, Cook, Matthew,Langue:
english
Journal:
Internal Medicine Journal
DOI:
10.1111/imj.13166
Date:
June, 2016
Fichier:
PDF, 209 KB
english, 2016